Evidence map›Paper›PMID 34095814›Full record

ArticlePediatric medicine (Hong Kong, China)2021

E-cigarette exposures, respiratory tract infections, and impaired innate immunity: a narrative review.

Aleks Kalininskiy, Julie Kittel, Nicholas E Nacca, Ravi S Misra, Daniel P Croft, Matthew D McGraw

Abstract read
In one paragraph

Article in Pediatric medicine (Hong Kong, China), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The effects of flavored vaped e-liquids on cultured human macrophages derived from the central and peripheral nervous systems.Toxicology in vitro : an international journal published in association with BIBRA · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aleks KalininskiyDepartment of Medicine, Pulmonary Diseases and Critical Care, University of Rochester Medical Center, Rochester NY, USA.
Julie KittelDepartment of Public Health, University of Rochester Medical Center, Rochester NY, USA.
Nicholas E NaccaDepartment of Emergency Medicine, University of Rochester Medical Center, Rochester NY, USA.
Ravi S MisraDepartment of Pediatrics, Pulmonology, University of Rochester Medical Center, Rochester NY, USA.
Daniel P CroftDepartment of Medicine, Pulmonary Diseases and Critical Care, University of Rochester Medical Center, Rochester NY, USA.
Matthew D McGrawDepartment of Pediatrics, Pulmonology, University of Rochester Medical Center, Rochester NY, USA.

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI BANSAL-TRAVERS, MAANSI · 2018 to 2022
$19.8M
Institutional Career Development CoreKL2TR001999 · NCATS · UNIVERSITY OF ROCHESTER · PI XIAO, JIN · 2016 to 2024
$5.2M
Integrated risk assessment and molecular characterization of pulmonary response to e-cigarette exposureR01HL139335 · NHLBI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI MIKHEEV, VLADIMIR B, QIAN, WEI-JUN · 2018 to 2021
$2.4M
Effect of Air Pollution on the Immune Response to Respiratory Viral Infection in AdultsK23ES032459 · NIEHS · UNIVERSITY OF ROCHESTER · PI CROFT, DANIEL PATRICK · 2021 to 2025
$1.2M
NCATS NIH HHS KL2 TR001999NCI NIH HHS U54 CA228110NHLBI NIH HHS R01 HL139335NIEHS NIH HHS K23 ES032459NIEHS NIH HHS L40 ES030909NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

Electronic cigarettes (e-cigarettes) are commonly used devices by adolescents and young adults. Since their introduction, the popularity of e-cigarettes has increased significantly with close to twenty percent of United States high school students reporting current use in 2020. As the number of e-cigarette users has increased, so have reports of vaping related health complications. Overall, respiratory tract infections remain one of the top ten leading causes of death in the US for every age group. Specific to the pediatric population, lower respiratory tract infections are the leading cause for hospitalization. This review highlights the current evidence behind e-cigarette exposure and its association with impaired innate immune function and the risk of lower respiratory tract infections. To date, various preclinical models have evaluated the direct effects of e-cigarette exposure on the innate immune system. More specifically, e-cigarette exposure impairs certain cell types of the innate immune system including the airway epithelium, lung macrophage and neutrophils. Identified effects of e-cigarette exposure common to the lung's innate immunity include abnormal mucus composition, reduced epithelial barrier function, impaired phagocytosis and elevated systemic markers of inflammation. These identified impairments in the lung's innate immunity have been shown to increase adhesion of certain bacteria and fungi as well as to increase virulence of common respiratory pathogens such as influenza virus,

Indexed as

e-cigaretteelectronic nicotine delivery system (ENDS)innate immunityLung

Identifiers

PMID34095814
PMCPMC8177080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.